Denied a Medical Treatment or Service? Attorney Scott Glovsky Can Help Being denied a medical treatment or service by your health insurance company ... Read More
Search Results for: Kaiser Permanente
Lemtrada Health Insurance Denial
Lemtrada (alemtuzumab) first received FDA approval on November 14, 2014, for relapsing forms of multiple sclerosis (MS), specifically for patients who ... Read More
Briumvi Health Insurance Denial
TG Therapeutics submitted a biologics license application (BLA) for Briumvi (ublituximab-xiiy) on September 28, 2021. In March and April of 2022, the ... Read More
Emgality Health Insurance Denial
FDA approval was granted to pharmaceutical company Lilly for Emgality (galcanezumab-gnlm) on September 27, 2018. Emgality was initially approved for ... Read More
Mavenclad Health Insurance Denial
Mavenclad (cladribine) was first submitted to the FDA in October 2009 as a potential oral short-course multiple sclerosis therapy. Merck then received ... Read More
Ocrevus Health Insurance Denial
Ocrevus is a drug used for relapsing and primary progressive forms of multiple sclerosis. The FDA granted priority review to Genentech for an Ocrevus ... Read More
